Back to Directory
Capromorelin
Growth Hormone SecretagoguesOrally active ghrelin agonist approved for veterinary use, investigated for humans.
Key Benefits
- ✓Appetite stimulation
- ✓GH release
- ✓Oral bioavailability
- ✓Veterinary approval
- ✓Investigated for human cachexia
Dosing Information
Dosage Range
Veterinary use
Frequency
Once daily (veterinary)
Typical Duration
Veterinary indication
Detailed Protocol
FDA-approved for veterinary use only. Human studies conducted but not approved. Oral administration.
About Capromorelin
Capromorelin is an orally active ghrelin receptor agonist. FDA-approved for appetite stimulation in dogs (Entyce). Human applications studied but not approved. Stimulates GH release and increases appetite.
Research Notes
FDA-approved for dogs in 2016. Human studies for cachexia showed efficacy but not pursued for approval. Demonstrates oral ghrelin agonist feasibility.
Potential Side Effects
- •Human use not approved
- •In dogs: diarrhea, vomiting
Always consult with a healthcare professional before starting any peptide therapy.